POSA354 Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients with FGFR2 Fusions/Rearrangements: Results from the Foenix-CCA2 Study.
Saved in:
| Title: | POSA354 Patient-Reported Outcomes in Futibatinib-Treated Intrahepatic Cholangiocarcinoma Patients with FGFR2 Fusions/Rearrangements: Results from the Foenix-CCA2 Study. |
|---|---|
| Authors: | Bridgewater, JA1 (AUTHOR), Hollebecque, A2 (AUTHOR), Furuse, J3 (AUTHOR), Goyal, L4 (AUTHOR), Meric-Bernstam, F5 (AUTHOR), Epstein, RS6 (AUTHOR), Morlock, R7 (AUTHOR), Salimi, T8 (AUTHOR), Wacheck, V8 (AUTHOR), Liu, M8 (AUTHOR), Benhadji, K8 (AUTHOR), Valle, JW9 (AUTHOR) |
| Source: | Value in Health. 2022 Supplement, Vol. 25 Issue 1, pS218-S219. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 10983015 |
|---|---|
| DOI: | 10.1016/j.jval.2021.11.1065 |
